Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins

Proteomics

Volumn 15, Issue 2-3, 2015, Pages 508-519

  Dammer, Eric B ^a   Lee, Andrew K ^a   Duong, Duc M ^a   Gearing, Marla ^a   Lah, James J ^a   Levey, Allan I ^a   Seyfried, Nicholas T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IMAC; MS; Neurodegeneration; Proteostasis; Systems biology

Indexed keywords

ALPHA CRYSTALLIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; PHOSPHOPEPTIDE; PROTEIN KINASE; SMALL HEAT SHOCK PROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; CELL JUNCTION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MIDDLE AGED; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SYNAPSE; TANDEM MASS SPECTROMETRY; VERY ELDERLY; WESTERN BLOTTING; AFFINITY CHROMATOGRAPHY; BRAIN; BRAIN CHEMISTRY; FEMALE; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; CHROMATOGRAPHY, AFFINITY; FEMALE; HEAT-SHOCK PROTEINS, SMALL; HUMANS; MALE; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN INTERACTION MAPS; PROTEIN KINASES; PROTEOMICS; TANDEM MASS SPECTROMETRY; TAU PROTEINS;

EID: 84921366995     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400189     Document Type: Article

References (45)

1. Nestler, E. J., Greengard, P., Protein phosphorylation in the brain. Nature 1983, 305, 583-588.
2. Cohen, P., The role of protein phosphorylation in human health and disease. Eur. J. Biochem. 2001, 268, 5001-5010.
3. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., Sudarsanam, S., The protein kinase complement of the human genome. Science 2002, 298, 1912-1934.
4. Querfurth, H. W., LaFerla, F. M., Alzheimer's disease. New Engl. J. Med. 2010, 362, 329-344.
5. Ghoshal, N., García-Sierra, F., Wuu, J., Leurgans, S. et al., Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp. Neurol. 2002, 177, 475-493.
6. Ballatore, C., Lee, V. M. Y., Trojanowski, J. Q., Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8, 663-672.
7. Sternberger, N. H., Sternberger, L. A., Ulrich, J., Aberrant neurofilament phosphorylation in Alzheimer disease. Proc. Nat. Acad. Sci. USA 1985, 82, 4274-4276.
8. Ulloa, L., Montejo de Garcini, E., Gomez-Ramos, P., Moran, M. A., Avila, J., Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. Brain Res. 1994, 26, 113-122.
9. Cole, A. R., Noble, W., Aalten, L. V., Plattner, F. et al., Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J. Neurochem. 2007, 103, 1132-1144.
10. Herskowitz, J. H., Feng, Y., Mattheyses, A. L., Hales, C. M. et al., Pharmacologic inhibition of ROCK2 suppresses amyloid-beta production in an Alzheimer's disease mouse model. J. Neurosci. 2013, 33, 19086-19098.
11. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., Anderton, B. H., Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosc. Lett. 1992, 147, 58-62.
12. Noble, W., Olm, V., Takata, K., Casey, E. et al., Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron. 2003, 38, 555-565.
13. Cole, G., Dobkins, K. R., Hansen, L. A., Terry, R. D., Saitoh, T., Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 1988, 452, 165-174.
14. Chin, J. Y., Knowles, R. B., Schneider, A., Drewes, G. et al., Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study. J. Neuropathol. Exp. Neurol. 2000, 59, 966-971.
15. Gong, C. X., Singh, T. J., Grundke-Iqbal, I., Iqbal, K., Phosphoprotein phosphatase activities in Alzheimer disease brain. J. Neurochem. 1993, 61, 921-927.
16. Stasyk, T., Huber, L. A., Mapping in vivo signal transduction defects by phosphoproteomics. Trends Mol. Med. 2012, 18, 43-51.
17. Xia, Q., Cheng, D., Duong, D. M., Gearing, M. et al., Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J. Proteome Res. 2008, 7, 2845-2851.
18. Herskowitz, J. H., Seyfried, N. T., Duong, D. M., Xia, Q. et al., Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J. Proteome Res. 2010, 9, 6368-6379.
19. Diz, A. P., Truebano, M., Skibinski, D. O., The consequences of sample pooling in proteomics: an empirical study. Electrophoresis 2009, 30, 2967-2975.
20. Dammer, E. B., Duong, D. M., Diner, I., Gearing, M. et al., Neuron enriched nuclear proteome isolated from human brain. J. Proteome Res. 2013, 12, 3193-3206.
21. Gozal, Y. M., Duong, D. M., Gearing, M., Cheng, D. et al., Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimers disease. J. Proteome Res. 2009, 8, 5069-5079.
22. Donovan, L. E., Dammer, E. B., Duong, D. M., Hanfelt, J. J. et al., Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease. Alzheimers Res. Ther. 2013, 5, 32.
23. Gould, J., Getz, G., Monti, S., Reich, M., Mesirov, J. P., Comparative gene marker selection suite. Bioinformatics 2006, 22, 1924-1925.
24. Rudrabhatla, P., Grant, P., Jaffe, H., Strong, M. J., Pant, H. C., Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. FASEB J. 2010, 24, 4396-4407.
25. Elias, J. E., Gygi, S. P., Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Meth. 2007, 4, 207-214.
26. Beausoleil, S. A., Villen, J., Gerber, S. A., Rush, J., Gygi, S. P., A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 2006, 24, 1285-1292.
27. Seyfried, N. T., Gozal, Y. M., Donovan, L. E., Herskowitz, J. H. et al., Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. J. Proteome. Res. 2012, 11, 2721-2738.
28. Wu, F., Wu, J., Nicholson, A. D., Echeverry, R. et al., Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the Ischemic Brain. J. Neurosci. 2012, 32, 9848-9858.
29. Zhou, J. Y., Hanfelt, J., Peng, J., Clinical proteomics in neurodegenerative diseases. Proteomics Clin. Appl. 2007, 1, 1342-1350.
30. Langfelder, P., Horvath, S., WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9, 559.
31. Seyfried, N. T., Gozal, Y. M., Dammer, E. B., Xia, Q. et al., Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyUb chains. Mol. Cell. Proteomics 2010, 9, 705-718.
32. Ficarro, S. B., Adelmant, G., Tomar, M. N., Zhang, Y. et al., Magnetic bead processor for rapid evaluation and optimization of parameters for phosphopeptide enrichment. Anal. Chem. 2009, 81, 4566-4575.
33. Huang da, W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols 2009, 4, 44-57.
34. Huang da, W., Sherman, B. T., Lempicki, R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37, 1-13.
35. Abisambra, J. F., Jinwal, U. K., Jones, J. R., Blair, L. J. et al., Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics. Curr. Neuropharmacol. 2011, 9, 623-631.
36. Mehlen, P., Arrigo, A.-P., The serum-induced phosphorylation of mammalian hsp27 correlates with changes in its intracellular localization and levels of oligomerization. Eur. J. Biochem. 1994, 221, 327-334.
37. Ahmad, M. F., Raman, B., Ramakrishna, T., Rao Ch, M., Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant. J. Mol. Biol. 2008, 375, 1040-1051.
38. Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T., Kato, K., αB crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 1993, 119, 203-208.
39. Kishi, M., Pan, Y. A., Crump, J. G., Sanes, J. R., Mammalian SAD kinases are required for neuronal polarization. Science 2005, 307, 929-932.
40. Jaleel, M., Villa, F., Deak, M., Toth, R. et al., The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation. Biochem. J. 2006, 394, 545-555.
41. Salminen, A., Kaarniranta, K., Haapasalo, A., Hiltunen, M. et al., Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease. Progress Neurobiol. 2012, 96, 87-95.
42. Matsumoto, G., Wada, K., Okuno, M., Kurosawa, M., Nukina, N., Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 2011, 44, 279-289.
43. Dammer, E. B., Na, C. H., Xu, P., Seyfried, N. T. et al., Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 2011, 286, 10457-10465.
44. Morishima, Y., Kanelakis, K. C., Murphy, P. J. M., Lowe, E. R. et al., The Hsp90 Cochaperone p23 is the limiting component of the multiprotein Hsp90/Hsp70-based chaperone system in vivo where it acts to stabilize the client protein·Hsp90 complex. J. Biol. Chem. 2003, 278, 48754-48763.
45. Chaudhry, U. A., Dore, S., Cytosolic prostaglandin E synthase: expression patterns in control and Alzheimer's disease brains. Am. J. Alzheimer's Dis. Other Dementias 2009, 24, 46-51.